Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)

NCT02296580 is registered in ClinicalTrials.gov with Nativis, Inc. as lead sponsor.

NCT NCT02296580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Lead sponsor
Nativis, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
September 30, 2021
Enrollment
37 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme